Singapore: Johnson & Johnson (J&J) revealed that it is aiming to apply for approval of 10 new drugs in the US and Europe, a polio vaccine for other parts of the world and 25 variations of its existing drugs by 2017. Dr Joaquin Duato,... Read more
Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of... Read more
Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement of... Read more
The year 2012 has been particularly eventful for South Korea. Not only has the nation elected its first woman president, Ms Park Geun-hye,... Read more
With an aim to become the number 1 hotspot for global bioscience industry in Asia, Singapore has committed $13.05 billion (S$16.1 billion)... Read more
New Delhi: Ranbaxy Laboratories has reached a final settlement agreement regarding a previously disclosed investigation by the US Department... Read more
Malaysia is now emerging as a manufacturing hub for international pharmaceutical companies and provides them smooth passage to set up manufacturing... Read more
Leveraging on the back of increasing sales of generic medicines, continued growth in chronic therapies and a greater penetration in rural... Read more
The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the country in its 12th... Read more
Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressure on the government... Read more
Singapore: The US Food and Drug Administration (FDA) has approved Arbor Pharmaceutical's New Drug Application (NDA) for Nymalize (nimodipine)... Read more
Singapore: Ms Deborah Dunsire, CEO, Millennium Pharmaceuticals, is leaving the company in an abrupt departure. Ms Dunsire fueled the emergence... Read more
Survey Box